These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 15031673

  • 1. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
    Lee EY, Shim MS, Kim MJ, Hong SY, Shin YG, Chung CH.
    Exp Mol Med; 2004 Feb 29; 36(1):65-70. PubMed ID: 15031673
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG, Yoo TH, Ryu DR, Cheon Park H, Ha SK, Han DS, Adler SG, Natarajan R, Kang SW.
    Kidney Int; 2005 Mar 29; 67(3):944-52. PubMed ID: 15698433
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ, Buck D, Cox AJ, Zhang Y, Gilbert RE.
    Am J Physiol Renal Physiol; 2007 Aug 29; 293(2):F565-74. PubMed ID: 17522264
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effects of valsartan on the renal vascular endothelial growth factor and its receptor flk-1 of diabetic rats].
    Tang WX, Chen ZJ, Huang SM, Tao Y, Fu P.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar 29; 39(2):223-6, 230. PubMed ID: 18630688
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin receptor blockade attenuates glomerulosclerosis progression by promoting VEGF expression and bone marrow-derived cells recruitment.
    Song SM, Wang CC, Qi SH, Xing L, Yang BF, Oite T, Li B.
    Nephrol Dial Transplant; 2012 Jul 29; 27(7):2712-9. PubMed ID: 22140134
    [Abstract] [Full Text] [Related]

  • 8. [Expression of VEGF in kidney of diabetic rats].
    Chen ZJ, Yang YB, Huang SM.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul 29; 38(4):633-6. PubMed ID: 17718428
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart.
    Jesmin S, Zaedi S, Yamaguchi N, Maeda S, Shimojo N, Masuzawa K, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun 29; 231(6):902-6. PubMed ID: 16741021
    [Abstract] [Full Text] [Related]

  • 10. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
    Vieitez P, Gómez O, Uceda ER, Vera ME, Molina-Holgado E.
    J Renin Angiotensin Aldosterone Syst; 2008 Jun 29; 9(2):96-102. PubMed ID: 18584585
    [Abstract] [Full Text] [Related]

  • 11. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S, Li Y, Zhao J, Zhang J, Huang Y.
    Biol Blood Marrow Transplant; 2013 Apr 29; 19(4):538-46. PubMed ID: 23295166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Sep 29; 48(9):4342-50. PubMed ID: 17724226
    [Abstract] [Full Text] [Related]

  • 14. Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats.
    Guo QY, Miao LN, Li B, Ma FZ, Liu N, Cai L, Xu ZG.
    Am J Physiol Endocrinol Metab; 2011 Apr 29; 300(4):E708-16. PubMed ID: 21285403
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
    Xu ZG, Miao LN, Cui YC, Jia Y, Yuan H, Wu M.
    Nephrol Dial Transplant; 2009 Jun 29; 24(6):1744-52. PubMed ID: 19103735
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies.
    Xu ZG, Ryu DR, Yoo TH, Jung DS, Kim JJ, Kim HJ, Choi HY, Kim JS, Adler SG, Natarajan R, Han DS, Kang SW.
    Nephrol Dial Transplant; 2005 Mar 29; 20(3):524-31. PubMed ID: 15647309
    [Abstract] [Full Text] [Related]

  • 18. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.